CN112760253A - Lactobacillus plantarum, antibacterial peptide and application thereof - Google Patents
Lactobacillus plantarum, antibacterial peptide and application thereof Download PDFInfo
- Publication number
- CN112760253A CN112760253A CN202110069093.3A CN202110069093A CN112760253A CN 112760253 A CN112760253 A CN 112760253A CN 202110069093 A CN202110069093 A CN 202110069093A CN 112760253 A CN112760253 A CN 112760253A
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- peptide
- antibacterial peptide
- lactobacillus plantarum
- plantaricin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 55
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 21
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 21
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 239000005452 food preservative Substances 0.000 claims abstract description 8
- 235000019249 food preservative Nutrition 0.000 claims abstract description 8
- 238000004321 preservation Methods 0.000 claims abstract description 7
- 229940124350 antibacterial drug Drugs 0.000 claims abstract description 5
- 238000000855 fermentation Methods 0.000 claims abstract description 4
- 230000004151 fermentation Effects 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 3
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 13
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 3
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 11
- 235000013305 food Nutrition 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 7
- 238000001228 spectrum Methods 0.000 abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 239000006041 probiotic Substances 0.000 abstract description 3
- 235000018291 probiotics Nutrition 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 16
- 241000191967 Staphylococcus aureus Species 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 12
- 229920001817 Agar Polymers 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 8
- 239000004365 Protease Substances 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 108010062877 Bacteriocins Proteins 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010053775 Nisin Proteins 0.000 description 2
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009920 food preservation Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000004309 nisin Substances 0.000 description 2
- 235000010297 nisin Nutrition 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- PIDRBUDUWHBYSR-UHFFFAOYSA-N 1-[2-[[2-[(2-amino-4-methylpentanoyl)amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O PIDRBUDUWHBYSR-UHFFFAOYSA-N 0.000 description 1
- GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 1
- 240000001606 Adenanthera pavonina Species 0.000 description 1
- 235000011470 Adenanthera pavonina Nutrition 0.000 description 1
- HNJNAMGZQZPSRE-GUBZILKMSA-N Arg-Pro-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O HNJNAMGZQZPSRE-GUBZILKMSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- TWYFJOHWGCCRIR-DCAQKATOSA-N Glu-Pro-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O TWYFJOHWGCCRIR-DCAQKATOSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Peptides Or Proteins (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
The invention discloses a lactobacillus plantarum, wherein a strain SHY21-2 is preserved in China center for type culture Collection with the preservation number of CCTCC NO: m2020043. The antibacterial peptide is produced by fermenting the lactobacillus plantarum to obtain fermentation liquor, and the antibacterial peptide is obtained by concentrating and purifying. Also discloses a coding gene of the antibacterial peptide, application of the lactobacillus plantarum in preparing antibacterial drugs or food preservatives, and application of the antibacterial peptide in preparing antibacterial drugs or food preservatives. The antibacterial peptide has a wide antibacterial spectrum, but has no inhibition effect on common probiotics unlike other reported antibacterial peptides, and has stable activity and good heat resistance; the antibacterial peptide can be digested and absorbed by human body, can be used as natural food preservative, and is safe and harmless to human body; the molecular weight of the peptide is small, the peptide is synthesized artificially, and the peptide can be used in the fields of food, medicine and the like.
Description
Technical Field
The invention relates to the technical field of microorganisms, in particular to a novel lactobacillus plantarum strain, an antibacterial peptide produced by the novel lactobacillus plantarum strain and application of the novel lactobacillus plantarum strain.
Background
The problem of microbial safety during food production, processing and storage has been a long-standing focus of attention in the food industry. The addition of chemical preservatives is a common preservative means at present, such as benzoic acid and salts thereof, sorbic acid and salts thereof and the like. However, as consumer demand for high quality food products increases, the potential hazards of chemical preservative additives are of increasing concern. Therefore, the preservation by using the nontoxic and harmless biological preservative is an important development direction in the future.
Antimicrobial peptides (AMPs) are favored by people because of their small molecular weight, ease of synthesis, non-toxicity, no pollution, no side effects, no drug resistance, and ability to be digested by the human body. However, the conventional bacteriocin used in the food industry is only Nisin, but Nisin has a narrow antibacterial spectrum and cannot inhibit gram-negative bacteria and yeasts. Therefore, the search for a high-efficiency broad-spectrum bacteriocin is of great significance. Antibacterial peptides are produced in insects, amphibians, aquatic animals, mammals including humans, and even plants and bacteria. Wherein, the lactobacillus can generate antibacterial peptide with wide antibacterial spectrum and stable property; and the lactic acid bacteria are widely present in various fermented foods, so that the food preservation is more convenient.
Disclosure of Invention
The invention aims to solve the problems and provide a novel lactobacillus plantarum strain, an antibacterial peptide produced by the strain and application of the strain.
In order to achieve the purpose, the invention adopts the technical scheme that:
the Lactobacillus plantarum strain is preserved in China Center for Type Culture Collection (CCTCC) with the preservation number of CCTCC NO: m2020043.
An antibacterial peptide produced by the lactobacillus plantarum.
Preferably, the amino acid sequence of the antibacterial peptide is RPNEPRLLLPR.
The preparation method of the antibacterial peptide comprises the steps of fermenting the lactobacillus plantarum to obtain fermentation liquor, and concentrating and purifying to obtain the antibacterial peptide.
A coding gene of the antibacterial peptide.
Preferably, the nucleotide sequence of the coding gene is shown as SEQ ID NO. 2.
The lactobacillus plantarum is applied to preparation of antibacterial drugs or food preservatives.
The application of the antibacterial peptide in preparing antibacterial drugs or food preservatives.
The invention has the beneficial effects that: the antibacterial peptide has a wide antibacterial spectrum, but has no inhibitory effect on common probiotics such as lactobacillus casei, lactobacillus helveticus and the like, different from other reported antibacterial peptides. The minimum inhibitory concentration to staphylococcus aureus is 156ug/mL, the activity is stable, and the activity is not obviously changed even if the staphylococcus aureus is treated at 121 ℃ for 30min, which shows that the staphylococcus aureus has good heat resistance. The antibacterial peptide can be digested and absorbed by human body, can be used as natural food antiseptic, and is safe and harmless to human body. The molecular weight of the peptide is small, the peptide is synthesized artificially, and the peptide can be used in the fields of food, medicine and the like.
Drawings
FIG. 1 is a high performance liquid chromatography elution curve of antimicrobial peptide plantaricin LP 21-2.
FIG. 2 is a mass spectrum of antimicrobial peptide plantaricin LP 21-2.
FIG. 3 is a graph of the mode of action of antimicrobial peptides on plantaricin LP 21-2 S.aureus.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to be limiting.
The experimental procedures in the following examples are conventional unless otherwise specified.
The main reagents are as follows:
MRS broth, purchased from czochralski microbiology ltd, cat #: 027312, respectively;
LB broth, available from beijing solibao technologies ltd, cat #: l8291.
Example 1: preparation, separation and purification of antibacterial peptide plantaricin LP 21-2
Sterilizing and cooling a 1LMRS liquid culture medium, inoculating 1% (v/v) of Lactobacillus plantarum SHY21-2 bacterial liquid cultured to logarithmic phase, culturing at 37 ℃ for 26h, centrifuging the obtained fermentation liquid at 4000rpm for 10min to obtain supernatant, adding 80% ammonium sulfate into the supernatant for salting out, centrifuging at 11000rpm for 15min to obtain precipitate, dissolving the precipitate obtained by centrifugation in 20mM citric acid-phosphate buffer solution with pH of 3.0, and conducting electric dilution on the solution to below 10mS/cm by using pure water after full dissolution. The diluted sample was separated by using an SP Sepharose Fsat Flow cation column (product of GE, USA); the buffer solution is as follows: solution a was 20mM citric acid-phosphate buffer solution having pH 3.0, and solution B was a solution in which NaCl was added. The eluate was collected and further separated by passing through a hydrophobic column Octyl Sepharose 4 Fast Flow (product of GE, USA); the buffers used for isolation were: the solution A contains 1.3mol/LNH2SO4Solution B was solution a without NH added thereto (20 mM citrate-phosphate buffer (pH 4))2SO4. The sample purified by the hydrophobic column was lyophilized and concentrated, and further purified by using Superdex-20010/300 GL gel column (product of GE, USA) as eluent, 20mM citrate-phosphate buffer solution with pH 4. Subjecting the peak with antibacterial activity after molecular sieve purification to final purification by reversed-phase high performance liquid chromatography (FIG. 1 is antibacterial peptide plantaricin LP 21-2 high performance liquid chromatography elution curve), to obtain antibacterial peptide plantaricin LP 21-2, wherein the purification conditions are as follows: agilent Shim-pack Arata C18(5 μm, 250L. times.4.6), liquid A: ultrapure water + 0.1% (v/v) trifluoroacetic acid, liquid B: acetonitrile + 0.1% trifluoroacetic acid; gradient elution procedure: 0-4min, 10% B; 4-33min 10% -100% B; 33-38min, 100% B; 38-43min, 100% -0% B; sample introduction amount: 100uL, detection wavelength: 220nm, flow rate: 0.6 mL/min. Detecting the bacteriostatic activity by an agar diffusion method, and selecting staphylococcus aureus as an indicator bacterium; the retention time for collecting the active peak is 4.835 min.
Lactobacillus plantarum SHY21-2 strain is delivered to China center for type culture Collection (CCTCC for short) for preservation in 1 month 2020, and the address is eight Lopa of the Wuchang region in Wuhan City in Hubei province. The preservation date is 1 month and 13 days 2020, and the preservation number is CCTCC NO: m2020043, classified under the name Lactobacillus plantarum SHY 21-2.
The antibacterial peptide plantaricin LP 21-2 is subjected to structure analysis and amino acid sequencing by an LC-MS/MS method, and FIG. 2 is a mass spectrum of the antibacterial peptide plantaricin LP 21-2. The amino acid sequence of the obtained antibacterial peptide plantaricin LP 21-2 is RPNEPRLLLPR (SEQ ID NO:1), and the molecular weight of the peptide is 1362.84 Da. The specific characteristics of the antibacterial peptide plantaricin LP 21-2 are as follows:
(a) sequence characteristics:
length: 11
Type (2): amino acid sequence
Chain type: single strand
Topological structure: linearity
(b) Molecular type: protein
(c) Suppose that: whether or not
(d) Antisense: whether or not
Example 2: antibacterial peptide plantarum LP 21-2 bacteriostasis experiment
(1) Bacterial inhibition spectrum
The antibacterial activity of the antibacterial peptide is measured by adopting an agar diffusion method, staphylococcus aureus is selected as an indicator bacterium, a thin layer of 1.5% sterile agar is poured into a sterile culture dish, and after the sterilization agar is solidified, an oxford cup is clamped by a pair of tweezers and is uniformly placed on the agar. Preparing an LB semisolid culture medium, sterilizing and cooling until hands are not scalded; then adding 1% (v/v) of indicator bacteria in logarithmic phase to LB semisolid culture medium (final concentration is 10)6CFU/mL) to prepare a culture medium containing the indicator bacteria, shaking uniformly, and pouring the culture medium onto an agar plate with an oxford cup, wherein the culture medium containing the indicator bacteria is one fourth of the culture medium in the oxford cup. And after the semisolid culture medium is solidified, taking out the oxford cup, opening the flat cover, and placing in an aseptic operating platform for 0.5h to volatilize water. The solution of antibacterial peptide plantarum LP 21-2 (concentration is 0.4mg/mL) purified in example 1 was pipetted 100. mu.L into the Oxford cup well of the plate, the plate was sealed with a sealing gel and placed in a refrigerator at 4 ℃ for 2h to allow the bacteriocin to diffuse sufficiently in the plate. Finally, the flat plate is placed in a constant temperature incubator at 37 ℃, the bacteriostasis effect is observed after overnight culture, and the bacteriostasis zone is measured by a vernier caliper. The results are shown in Table 1, and the plantaricin LP 21-2 has certain inhibitory effect on common food-borne pathogenic bacteria and food spoilage bacteria, which indicates that the plantaricin LP 21-2 is a broad-spectrum antibacterial peptide. However, the plantaricin LP 21-2 has no inhibition effect on common probiotics, which is obviously different from other reported antibacterial peptides, and the plantaricin LP 21-2 has the remarkable characteristics, and can be used as a natural food preservative in foods such as yoghourt and the like.
TABLE 1 bacteriostatic effect of plantaricin LP 21-2 on different bacteria
(2) Minimum inhibitory concentration against Staphylococcus aureus
The RP-HPLC purified plantaricin LP 21-2 and Staphylococcus aureus liquid were mixed in a 96-well plate, and double diluted with LB liquid medium, with no antimicrobial peptide added as a control. After incubation at 37 ℃ for 12h, OD was determined600The value is obtained. As a result, the minimum inhibitory concentration of plantaricin LP 21-2 to staphylococcus aureus was found to be 156 ug/mL.
Example 3: sensitivity of antibacterial peptide plantaricin LP 21-2 to heat and protease
0.5mL of the antibacterial peptide plantaricin LP 21-2 (concentration 0.4mg/mL) solution purified in example 1 was dispensed into 1.5mL centrifuge tubes, heated at 60 ℃ and 80 ℃ for 10min and 30min, respectively, at 100 ℃ and 121 ℃ for 15min and 30min, respectively, and then treated at room temperature as a control. After the treatment, staphylococcus aureus is used as an indicator bacterium, the antibacterial activity is detected by an agar diffusion method, and 100uL of antibacterial peptide solution is added into each Oxford cup hole. Samples purified by gel column chromatography were weighed out using staphylococcus aureus as indicator bacteria and dissolved in 1mL of buffer solution at pH 2, 3, 4, 5, 6, 7, 8, and 9, respectively, at a concentration of 0.4 mg/mL. After being soaked in water bath at 37 ℃ for 4 h; the antimicrobial activity was checked by agar diffusion using a blank buffer with pH 2, 3, 4, 5, 6, 7, 8, 9, and 100uL bacteriocin solution was added to each well of oxford cup, 3 replicates each. Dissolving an antibacterial peptide sample in a buffer solution corresponding to protease, and respectively adding pepsin, proteinase K, papain and trypsin solution to mix uniformly, wherein the final concentration of the enzyme is 1mg/mL, and the final concentration of the antibacterial peptide is 0.4 mg/mL. After being soaked in water at 37 ℃ for 4 hours, the pH value of the solution is adjusted to 4 by using 3mol/L HCI and 3mol/L NaOH, the residual activity after each protease treatment is detected, a sample which is not treated by the protease is used as a reference, the antibacterial activity is detected by an agar diffusion method, and 100uL of antibacterial peptide solution is added into each Oxford cup hole. The results are shown in tables 2, 3 and 4.
TABLE 2 bacteriostatic effect of plantaricin LP 21-2 after different temperature treatment
TABLE 3 bacteriostatic activity of plantaricin LP 21-2 under different pH conditions
TABLE 4 bacteriostatic effect of plantaricin LP 21-2 after different enzyme treatments
As can be seen from Table 2, the plantaricin LP 21-2 is still active after high temperature treatment, indicating that it has good heat resistance. As can be seen from Table 3, plantaricin LP 21-2 has bacteriostatic activity in the pH range of 2-5, indicating that the antimicrobial peptide is suitable for use in acidic foods. As shown in Table 4, the plantaricin LP 21-2 can be inactivated by pepsin, trypsin and papain in the human digestive tract, which indicates that the plantaricin LP 21-2 is safe for food preservation.
Example 4: mode of action of antibacterial peptide plantaricin LP 21-2
Adding 1% (v/v) of staphylococcus aureus liquid into 5mL of LB liquid culture medium, and culturing at 37 ℃ to logarithmic phase; the antibacterial peptide purified by R-HPLC in example 1 was weighed and added to the bacterial solution to a final concentration of 0.4mg/mAnd L. After addition of the sample, the broth was further incubated at 37 ℃. After inoculating the bacterial liquid, measuring the OD of the bacterial liquid every 2h600A value; after the antibacterial peptide is added, sampling at 0, 0.5, 1, 1.5, 2, 2.5, 3 and 4 hours to determine the total number of colonies; no bacteriocin was added as a control. As shown in FIG. 3, OD was obtained after adding the antimicrobial peptide to Staphylococcus aureus solution600The value did not increase any more and the number of viable cells of Staphylococcus aureus decreased sharply starting from 1.5h, after 3h of treatment the number of viable cells was 0. The antibacterial peptide plantaricin LP 21-2 is shown to act on staphylococcus aureus in a bactericidal mode.
Example 5: gene sequence of basic structure of coded antibacterial peptide plantaricin LP 21-2
After the whole gene sequencing of the strain SHY21-2 was completed, the position of the gene encoding plantaricin LP 21-2 was predicted using BLASTP program based on the amino acid sequence of plantaricin LP 21-2. Finally, the sequence of the gene coding the antibacterial peptide plantaricin LP 21-2 is determined to be shown in SEQ ID NO. 2, and the open reading frame of the gene is underlined, namely the gene coding the plantaricin LP 21-2 precursor basic structure.
The SEQ ID NO 2 sequence is as follows:
TTAATGATTTATTTGAGCTGTGGAAGGTAAACGCGGTTCTGAATGTCTCTTAAAATCTGTCTCAAATATTGACTTCAATCCAATCCGCGCCTCGCGTTGGTATGCATATTGGTCTCGTTTTAGAAACAAAGTTTCCATGGATTTTTGTTTAAATTCTTTCAAAGAGATATTCTCTTCAATTTTATCAGAATAATAGTGAACATTTTTAAATTCCGCATGATATTTTGAAAAATTAGAATCCAATTTTTGCAGAAATTTTTGAGCATCAATCATAACTGGAATTCTCTTTTTGTTATCGCTCAGACGATTTAAATCATTAATGACTGACTTCTTTAACGTATATTGATTTCTTGAATCGTCATAGTCTATACAATCAAAATCTTCTATTAAATCTAAGTTAATCAGAGATAAAATCCCCTTTTCTCTGACCCATTGAGGTACAGAAACTATTCTTATTGTATCGCCTTCACAAAAGTCTATCTTTTTCCCATTAATAGAGACAAAGATATCCGAATTTGCTGCATCTAAATTAAGTATCCTAGATCCCTCAAAAGCATCTGCAATTACATCTCCATCATTTTCCAAATCGATGAAATATCC TAATTGTGAAAAATGTAACTCACCTTCATTAATAAATTTATCGACATACTTTTTTTCAAAAAACTTTATCACACAT CCTGGTTGAGTATCGTTAATCAT。
sequence listing
<110> university of southwest
<120> Lactobacillus plantarum, antibacterial peptide and application thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 11
<212> PRT
<213> Artificial sequence (Artificial sequence)
<400> 1
Arg Pro Asn Glu Pro Arg Leu Leu Leu Pro Arg
1 5 10
<210> 2
<211> 699
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 2
ttaatgattt atttgagctg tggaaggtaa acgcggttct gaatgtctct taaaatctgt 60
ctcaaatatt gacttcaatc caatccgcgc ctcgcgttgg tatgcatatt ggtctcgttt 120
tagaaacaaa gtttccatgg atttttgttt aaattctttc aaagagatat tctcttcaat 180
tttatcagaa taatagtgaa catttttaaa ttccgcatga tattttgaaa aattagaatc 240
caatttttgc agaaattttt gagcatcaat cataactgga attctctttt tgttatcgct 300
cagacgattt aaatcattaa tgactgactt ctttaacgta tattgatttc ttgaatcgtc 360
atagtctata caatcaaaat cttctattaa atctaagtta atcagagata aaatcccctt 420
ttctctgacc cattgaggta cagaaactat tcttattgta tcgccttcac aaaagtctat 480
ctttttccca ttaatagaga caaagatatc cgaatttgct gcatctaaat taagtatcct 540
agatccctca aaagcatctg caattacatc tccatcattt tccaaatcga tgaaatatcc 600
taattgtgaa aaatgtaact caccttcatt aataaattta tcgacatact ttttttcaaa 660
aaactttatc acacatcctg gttgagtatc gttaatcat 699
Claims (8)
1. The Lactobacillus plantarum strain is preserved in China Center for Type Culture Collection (CCTCC) with the preservation number of CCTCC NO: m2020043.
2. An antimicrobial peptide, characterized by: the antimicrobial peptide is produced by the lactobacillus plantarum of claim 1.
3. The antimicrobial peptide of claim 2, wherein: its amino acid sequence is RPNEPRLLLPR.
4. A process for the preparation of an antimicrobial peptide according to claim 2 or 3, characterized in that: is obtained by fermenting lactobacillus plantarum of claim 1 to obtain a fermentation broth, concentrating and purifying to obtain the antibacterial peptide.
5. A gene encoding the antibacterial peptide according to claim 3.
6. The coding gene of claim 5, wherein: the nucleotide sequence is shown in SEQ ID NO. 2.
7. Use of the lactobacillus plantarum of claim 1 in the preparation of an antibacterial drug or food preservative.
8. Use of the antimicrobial peptide of claim 2 or 3 for the preparation of an antimicrobial medicament or a food preservative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110069093.3A CN112760253B (en) | 2021-01-19 | 2021-01-19 | Lactobacillus plantarum, antibacterial peptide and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110069093.3A CN112760253B (en) | 2021-01-19 | 2021-01-19 | Lactobacillus plantarum, antibacterial peptide and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112760253A true CN112760253A (en) | 2021-05-07 |
CN112760253B CN112760253B (en) | 2023-05-23 |
Family
ID=75703142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110069093.3A Active CN112760253B (en) | 2021-01-19 | 2021-01-19 | Lactobacillus plantarum, antibacterial peptide and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112760253B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112094323A (en) * | 2020-09-29 | 2020-12-18 | 福州大学 | Lactobacillus plantarum-derived broad-spectrum antibacterial peptide and application thereof |
CN114276951A (en) * | 2021-12-01 | 2022-04-05 | 江南大学 | Lactobacillus plantarum capable of producing antibacterial peptide with broad-spectrum antibacterial activity |
CN114681588A (en) * | 2022-02-17 | 2022-07-01 | 中山大学 | Application of polypeptide EN-9 in preparation of product for treating acne |
CN114854622A (en) * | 2022-03-10 | 2022-08-05 | 西南大学 | Lactobacillus plantarum with broad-spectrum activity of inhibiting mold and pathogenic bacteria and capable of producing multiple antibacterial metabolites and application of lactobacillus plantarum |
CN117100772A (en) * | 2023-09-20 | 2023-11-24 | 西南大学 | Application of Lactobacillus plantarum SHY21-2 in increasing endurance and relieving fatigue |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002249757A1 (en) * | 2000-10-17 | 2002-08-06 | Cubist Pharmaceuticlas, Inc. | Compositions and methods relating to the daptomycin biosynthetic gene cluster |
CN105087422A (en) * | 2015-05-06 | 2015-11-25 | 南京农业大学 | Lactobacillus plantarum JLA-9, bacteriocin produced by same and production identification method of bacteriocin |
-
2021
- 2021-01-19 CN CN202110069093.3A patent/CN112760253B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002249757A1 (en) * | 2000-10-17 | 2002-08-06 | Cubist Pharmaceuticlas, Inc. | Compositions and methods relating to the daptomycin biosynthetic gene cluster |
CN105087422A (en) * | 2015-05-06 | 2015-11-25 | 南京农业大学 | Lactobacillus plantarum JLA-9, bacteriocin produced by same and production identification method of bacteriocin |
Non-Patent Citations (1)
Title |
---|
PONGSAK RATTANACHAIKUNSOPON等: "Isolation and Preliminary Characterization of a Bacteriocin Produced by Lactobacillus plantarum N014 Isolated from Nham,a Traditional Thai Fermented Pork", 《JOURNAL OF FOOD PROTECTION》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112094323A (en) * | 2020-09-29 | 2020-12-18 | 福州大学 | Lactobacillus plantarum-derived broad-spectrum antibacterial peptide and application thereof |
CN112094323B (en) * | 2020-09-29 | 2022-04-01 | 福州大学 | Lactobacillus plantarum-derived broad-spectrum antibacterial peptide and application thereof |
CN114276951A (en) * | 2021-12-01 | 2022-04-05 | 江南大学 | Lactobacillus plantarum capable of producing antibacterial peptide with broad-spectrum antibacterial activity |
CN114276951B (en) * | 2021-12-01 | 2023-10-03 | 江南大学 | Lactobacillus plantarum capable of producing antibacterial peptide with broad-spectrum antibacterial activity |
CN114681588A (en) * | 2022-02-17 | 2022-07-01 | 中山大学 | Application of polypeptide EN-9 in preparation of product for treating acne |
CN114681588B (en) * | 2022-02-17 | 2023-06-06 | 中山大学 | Application of polypeptide EN-9 in preparation of product for treating acne |
CN114854622A (en) * | 2022-03-10 | 2022-08-05 | 西南大学 | Lactobacillus plantarum with broad-spectrum activity of inhibiting mold and pathogenic bacteria and capable of producing multiple antibacterial metabolites and application of lactobacillus plantarum |
CN114854622B (en) * | 2022-03-10 | 2023-09-05 | 西南大学 | Lactobacillus plantarum with broad-spectrum mold and pathogenic bacteria inhibiting activity and capable of producing various antibacterial metabolites and application thereof |
CN117100772A (en) * | 2023-09-20 | 2023-11-24 | 西南大学 | Application of Lactobacillus plantarum SHY21-2 in increasing endurance and relieving fatigue |
Also Published As
Publication number | Publication date |
---|---|
CN112760253B (en) | 2023-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112760253B (en) | Lactobacillus plantarum, antibacterial peptide and application thereof | |
Peng et al. | A broad-spectrum novel bacteriocin produced by Lactobacillus plantarum SHY 21–2 from yak yogurt: Purification, antimicrobial characteristics and antibacterial mechanism | |
CN104151415B (en) | A kind of natural antibacterial peptide Alligatorin4 and its application | |
CN105175518B (en) | The bacteriocin and preparation method thereof that bacillus coagulans FM603 is generated | |
CN105176874B (en) | Bacillus coagulans FM603 and its application | |
US6746672B2 (en) | Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis | |
CN103748220A (en) | Bacteriocin derived from lactobacillus rhamnosus | |
Mohanty et al. | Bioactive potential assessment of antibacterial peptide produced by Lactobacillus isolated from milk and milk products | |
CN106701833B (en) | Bacteriostatic paenibacillus fermentation liquor extract | |
Cui et al. | Purification and characterization of a novel bacteriocin produced by Enterococcus faecalis CG-9 from human saliva | |
CN103103196A (en) | Modified goat defensin gene and preparation method and application thereof | |
CN109748972A (en) | A kind of cytoglobin-source of people lactoferrin peptide fusion protein, gene and application | |
Arakawa et al. | Bacteriocin production of probiotic Lactobacillus gasseri LA39 isolated from human feces in milk‐based media | |
CN105104712B (en) | A kind of additive for microbe feedstuff and preparation method thereof | |
CN106701834B (en) | Preparation method of bacteriostatic paenibacillus fermentation liquor extract | |
CN107325158B (en) | Antibacterial peptide CNAP- I, antibacterial peptide CNAP- II and its preparation method and application | |
CN114149483B (en) | Antibacterial peptide composition and application thereof | |
KR100273742B1 (en) | Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047) | |
Al-Taie et al. | Evaluation of Streptocin SH3, a Bacteriocin produced by Streptococcus sanguinis isolated from Human Dental Plaque | |
CN103204938A (en) | Hybrid antibacterial peptide LFB_Mel and preparation method thereof | |
Iqbal et al. | Isolation and partial characterization of Bac201: A plasmid‐associated bacteriocin‐like inhibitory substance from Staphylococcus aureus AB201 | |
JP5622110B2 (en) | New lactic acid bacteria | |
Chang et al. | Growth and survival of Escherichia coli O157: H7 during the fermentation and storage of diluted cultured milk drink | |
Kamel et al. | Antibacterial Bioactivity of Some Lactic Acid Bacteria Isolated from Various Egyptian Products | |
CN114874937B (en) | Separation and purification of bacteriocin produced by lactobacillus sake and antibacterial application and lactobacillus used by same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |